Delivery Order SPE2DB22D3301-SPE2DB26FX3NF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,584.61 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child delivery order under a larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a $10,065.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $16,057.06 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $7,677.00 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials on September 29, 2025, with completion scheduled for September 30, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $17,870.71 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 ml vials on August 27, 2025, with completion targeted for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,967.59 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a single delivery of the pharmaceutical product to support federal medical procurement needs. The performance location is identified as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $17,406.92 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials. This competitively awarded, firm fixed-price contract was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials valued at $3,070.80, with an ultimate completion date of August 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a $15,982.18 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Bridion 200 mg/2 ml vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, scheduled for completion by September 29, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3NFDelivery Order
The Defense Logistics Agency (DLA) awarded a $19,169.87 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 ml vials on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the DLA and Defense Health Agency. The company supplies a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains in support of military and veteran healthcare systems. As a child contract under the larger SPE2DX vehicle, this delivery order exemplifies AmerisourceBergen's role as a critical vendor within the DLA's Medical Supply Chain, supporting the distribution of essential medications and medical supplies to federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 10/20/25 |